News

Friday, 11 May 2012 - 13:59

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v Cipla Life Sciences and Others in the patent dispute over the cancer medicine Docetaxel (brand name Taxotere). The Treatment Action Campaign (TAC) has been admitted to the proceedings as amicus curiae (friend of the court) and is represented by SECTION27. TAC will argue for the protection of the rights of people in need of medicines in disputes of this nature.

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v...

Read more
Friday, 11 May 2012 - 12:06

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v Cipla Life Sciences and Others in the patent dispute over the cancer medicine Docetaxel (brand name Taxotere). The Treatment Action Campaign (TAC) has been admitted to the proceedings as amicus curiae (friend of the court) and is represented by SECTION27. TAC will argue for the protection of the rights of people in need of medicines in disputes of this nature.

Docetaxel is used in the treatment of various cancers, including breast and lung cancers. The medicine has also been...

Read more
Thursday, 10 May 2012 - 16:29

Statement by the Treatment Action Campaign, the HIV Clinicians Society of Southern Africa, the Rural Health Advocacy Project, the Rural Doctors Association of Southern Africa, SECTION27 and Médecins Sans Frontières

There have been ongoing shortages of antiretroviral medicines, specifically tenofovir (TDF) and abacavir (ABC) since March in facilities across South Africa. These shortages are compromising the health of patients taking these medicines. We call for urgent resolution of the shortages and for an enquiry into their cause.

Statement by the...

Read more
Friday, 20 April 2012 - 11:43

 

The TAC National Council has resolved to seek admission in a legal dispute between the brand name drug company Aventis Pharma and the generic company Cipla, over a claim of patent infringement on a drug that treats cancer called Docetaxel. SECTION27 will act as attorneys for TAC. This briefing note sets out the background to the legal dispute and explains why TAC is arguing that the Supreme Court of Appeal must consider the right of access to health care services when it judges this dispute.

 

...

Read more
Friday, 13 April 2012 - 15:16

Please join us for an evening filled with fabulous fun to raise funds for the Treatment Action Campaign  the World's most effective Aids group.

Your R100 cover charge will go straight to the TAC and includes a show by the amazing Odidiva, a raffle ticket and a live auction. See attached for more info.

Please pass this on to anyone who you think may be...

Read more

Pages